Stemtech today announced VISION 2023 concerning the exciting developments planned for the new year.
President and Chief Operating Officer, John W. Meyer says that “VISION 2023 for Stemtech was built on the foundations we enacted over the course of 2022.
“Our efforts were rewarded with a 20% growth of new Independent Business Partners (IBPs) and customers over FY 2021. We anticipate that this growth rate will actually be exceeded this year.
We introduced the powerful AdvanceOffice Mobile app for all of our distributors which enables them to operate their entire business via the app.
We launched a new proprietary blend named “CellectOne™”, a Rapid Renew Stem Cell Peptide Night Cream; we held our international conference in Cancun, Mexico this past December. Each one of these investments have generated exciting growth far beyond our expectations”
“For the upcoming fiscal year, we expect to increase our customer base as well as revenue. Much of this stems not only from our new product lines or increasing sales, but as much our human factor.
Our Field attendees came away from our Cancun event filled with excitement and new strategies to take to their customers, sharing the many opportunities of Stemtech.
We believe that sales will increase considerably in 2023